Skip to main content

Vanderbilt Ingram Cancer Center Archives

VICC researchers featured at AACR Annual Meeting

Apr. 8, 2021—Researchers from Vanderbilt-Ingram Cancer Center will have a robust presence during the first session of the American Association for Cancer Research (AACR) Annual Meeting, April 10-15, as presenters, panelists and authors.

Read more


Vanderbilt mourns the passing of Pierre Massion

Apr. 6, 2021—Pierre Massion, MD, Cornelius Vanderbilt Chair and Professor of Medicine, an internationally known expert on early detection and prevention strategies for lung cancer, died April 4 of an apparent heart attack. He was 58.

Read more


New Clinician Spotlight: Robert Ramirez

Apr. 5, 2021—Robert Ramirez, DO, a thoracic and neuroendocrine oncologist, has joined Vanderbilt-Ingram Cancer Center after practicing at Ochsner Medical Center and Louisiana State University (LSU) Health Science Center in New Orleans.

Read more


Total skin electron therapy offered in Spring Hill

Mar. 26, 2021—A radiation therapy device for the treatment of a rare cancer has been designed, custom built and installed at Vanderbilt-Ingram Cancer Center at Maury Regional Spring Hill, offering patients from Alabama, Mississippi, Georgia and southern Tennessee more convenient care.

Read more


Forty-three percent of melanoma patients have chronic complications from immunotherapies

Mar. 25, 2021—Chronic side effects among melanoma survivors after treatment with anti-PD-1 immunotherapies are more common than previously recognized, according to a study published March 25 in JAMA Oncology.

Read more


Effort seeks to enroll more Black patients in lung cancer trials

Mar. 25, 2021—Researchers from Vanderbilt University Medical Center are part of a multi-institutional study that aims to improve participation in lung cancer clinical trials among Black patients from Southern states.

Read more


Prostate cancer microenvironment

Mar. 23, 2021—Distinct cancer-associated fibroblasts in the prostate tumor microenvironment may influence tumor progression and could point to new therapeutic targets.

Read more


EGFR Resisters/LUNGevity fund lung cancer research

Mar. 18, 2021—Christine Lovly, MD, PhD, associate professor of Medicine in the Division of Hematology and Oncology and Ingram Professor of Cancer Research, is one of two inaugural recipients of the EGFR Resisters/LUNGevity Lung Cancer Research Award.

Read more


Study incorporates genetics with smoking history to identify high-risk smokers for lung cancer screening

Mar. 9, 2021—A study by Vanderbilt researchers that analyzed both smoking history and genetic risk variants for lung cancer supports modifying current guidelines to include additional smokers for lung cancer screening.

Read more


Markers for breast cancer progression

Mar. 9, 2021—Vanderbilt researchers clarify how a microRNA associated with triple-negative breast cancer survival inhibits cancer progression, suggesting new treatment strategies.

Read more


Process ensures follow-up of incidental radiology findings

Feb. 4, 2021—When people go to an emergency room after being injured, suspicious images may show up on their imaging scans that are unrelated to their injuries but may be indicative of cancer. A team at Vanderbilt University Medical Center recently established a better process for ensuring these patients receive follow-up diagnostic care, an initiative that is already receiving national recognition.

Read more


Gene network for leukemia factor

Feb. 4, 2021—A new method speeds the analysis of factors that control gene expression from days to minutes, allowing researchers to uncover new targets for cancer treatment.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more